Myotonic dystrophy (DM) is the most common adult muscular dystrophy an
d follows an autosomal dominant pattern of inheritance. Up to now, the
clinical diagnosis of DM was based on symptoms presented such as ence
phalopathy, facies myopathica, paresthesia, atrophy, myotonia, mental
retardation, cataract, diabetes, cardiac conduction defects and electr
o myography. Since 1991 the specific molecular defect in DM is known a
nd a respective diagnosis is possible. The mutation responsible for DM
is the expansion of an unstable trinucleotide repeat, (CTG)n, in the
3'-untranslated region of the myotonin protein kinase gene. it is now
generally accepted that the CTG repeat length correlates with the clin
ical category and the age at onset of the disease; therefore genetic t
ests are essential in monitoring and management of DM-patients and the
ir family members.Based on the average incidence in Europe about 1000
affected individuals can be expected in Austria, a high percentage of
whom is, however, not recognized as carries of the DM-mutation. After
having established a genetic diagnosis in Austria allowing the detecti
on of this mutation in DM-patients and their relatives, improvement of
the diagnostic procedure should be possible.